India's Drug Multinationals: Growth Strategies and Global Industry Dynamics

The Politics and Culture of Globalisation: India and Australia

Volumn , Issue , 2017, Pages 181-198

  Löfgren, Hans ^a  

^a DEAKIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 66749165797     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4324/9781315148656     Document Type: Chapter

References (53)

1. Anderson, P., 2007. 'Jottings on the Conjuncture', New Left Review, 48: 5-37.
2. Anonymous, 2007. The pharm exec 50: holding pattern, www.pharmexec.com/ pharmexec/issue/issueDetail.jsp?id=11913.
3. Anonymous 2008. The pharm exec 50: the winners' circle, in Pharmaceutical Executive, www.pharmexec.findpharma.com/.
4. Benner, M., 2004. 'Catching Up in Pharmaceuticals: Government Policies and the Rise of Genomics', Australian Health Review, 28(2): 161-70.
5. Bhagat, M., 1982. Aspects of Drug Industry in India, Centre for Education and Documentation, Mumbai.
6. Blaisdell, P., 2005. 'Outsourcing in Pharmaceutical Development', BDMA Newsletter (Bulk Drug Manufacturers Association India), August: 8-10.
7. Chandler, A., 1990. Strategy and Structure: Chapters in the History of the Industrial Enterprise, MIT Press, Cambridge, Mass.
8. Chataway, J., Kale, D., and D. Wield, 2007. 'The Indian Pharmaceutical Industry Before and After TRIPS', Technology Analysis & Strategic Management, 19(5): 559-63.
9. Chaturvedi, K., Chataway, J., and D. Wield, 2007. 'Policy, Markets and Knowledge: Strategic Synergies in Indian Pharmaceutical Firms', Technology Analysis & Strategic Management, 19(5): 568-88.
10. Chaudhuri, S., 2005a. 'R&D for Development of New Drugs for Neglected Diseases: A Study Commissioned by the World Health Organization', Commission on Intellectual Property Rights Innovation and Public Health, Geneva.
11. Chaudhuri, S. 2005b. The WTO and India's Pharmaceuticals Industry: Patent Protection, TRIPS, and Developing Countries, Oxford University Press, New Delhi.
12. Chaudhuri, S. 2007. 'The Gap Between Successful Innovation and Access to its Benefits: Indian pharmaceuticals', European Journal of Development Research, 19(1): 49-65.
13. Chibber, V., 2003. Locked in Place: State-building and Late Industrialization in India, Princeton University Press, Princeton.
14. Cipla, 2005. Annual report 2004-2005, www.cipla.com.
15. Class, S., 2005. 'Whither Generics?: Why Major Restructuring Lies Ahead', Journal of Generic Medicines, 2(3): 232-39.
16. Cockburn, I.M., 2004. 'The Changing Structure of the Pharmaceutical Industry', Health Affairs, 23(1): 10-22.
17. Comanor, W., 2007. 'The Economics of Research and Development in the Pharmaceutical Industry', in Sloan, F., and C.R. Hsieh (eds), Pharmaceutical Innovation: Incentives, Competition, and Cost-Benefit Analysis in International Perspective, pp. 54-72, Cambridge University Press, Cambridge.
18. Cygnus Business Consulting and Research, 2005. Indian Pharmaceuticals: Industry Insight, Cygnus, Hyderabad.
19. Dyer, G., 2004. 'A laboratory for globalisation: how India hopes to reshape the world drugs industry', The Financial Times, 18 August, p. 9.
20. Ernst and Young, 2006. Beyond borders: the local biotechnology report 2006, www.ey.com/global/content.nsf/International/Biotechnology_ Report_2006_Beyond_Borders.
21. Galambos, L., and J. Sturchio, 1997. 'The Transformation of the Pharmaceutical Industry in the Twentieth Century', in Krige, J., and D. Pestre (eds), Science in the Twentieth Century, pp. 227-52, Harwood Academic Publishers, Amsterdam.
22. Garnier, J.P., 2008. 'Rebuilding the R&D Engine in Big Pharma', Harvard Business Review, 86(5): 68-76.
23. Gehl Sampath, P., 2005. Economic Aspects of Access to Medicines after 2005: Product Patent Protection and Emerging Firm Strategies in the Indian Pharmaceutical Market, United Nations University-Institute for New Technologies (UNU-INTECH), Maastricht.
24. Hamied, Y.K., 2005. Address to the sixty-ninth annual general meeting, Cipla, www.cipla.com/corporate profile/financial/cm69.htm.
25. Heinen, C., and R. Perry, 2006. 'Big Pharma's Indian Renaissance', Scrip Magazine, February: 33-5.
26. IDMA, 2004, Global Bulk Drug Industry, Bulk Drug Manufacturers Association, Hyderabad.
27. Kale, D., and D. Wield, 2006. Exploitative and Explorative Learning as a Response to the TRIPS Agreement in Indian Pharmaceutical Firms: Some Implications for Other Developing Countries, Open University Business School, www.open.ac.uk/ikd/workingpapers/ workingpaper_11.pdf.
28. Kamath, G., 2005. 'Israeli drug giant eyes Cipla, Dr Reddy's', www.rediff. com/money/2005/may/13teva.htm.
29. Krishnan, G.S., 2006. 'India Learns How to Discover Drugs', Businessworld, 19 June: 30-6.
30. Lall, S., 1974. 'The International Pharmaceutical Industry and Less- Developed Countries, with Special Reference to India', Oxford Bulletin of Economics and Statistics, 36(3): 143-72.
31. Lanjouw, J., 1998. The Introduction of Pharmaceutical Product Patents in India: "Heartless Exploitation of the Poor and Suffering"?, National Bureau of Economic Research, Cambridge, Mass.
32. Malhotra, P., and H. Löfgren, 2004. 'India's Pharmaceutical Industry: Hype or High Tech Take-off?', Australian Health Review, 28(2): 182-93.
33. Mathew, T., and M. Torreblanca, 2005. 'India Steps Up to the Plate', Scrip Magazine, November: 47-9.
34. Miller, J., 2008. Old model in new clothes, www. pharmtech.findpharma. com/pharmtech/Old-Model-in-New-Clothes/ArticleStandard/Article/ detail/489205.
35. Mittra, J., 2007. 'Life Science Innovation and the Restructuring of the Pharmaceutical Industry: Mergers, Acquisitions and Strategic Alliance Behaviour of Large Firms', Technology Analysis & Strategic Management, 19(3): 279-301.
36. Moza, V., 2005. Opportunities and challenges for clinical research in India, www.expresspharmaonline.com/20051215/ipcspecial05.shtml.
37. Myrdal, G., 1972. Asian Drama: An Inquiry into the Poverty of Nations, Allen Lane, London.
38. Perlitz, U., 2008. India's pharmaceutical industry on course for globalisation, Deutche Bank Research, www.dbresearch.com/servlet/reweb2.ReWEB? rwkey=u33878514.
39. Ranbaxy, 2007. Annual Report 2007, Ranbaxy, New Delhi.
40. Rangnekar, D., 2006. 'No Pills for Poor People: Understanding the Disembowelment of India's Patent Regime', Economic and Political Weekly, 41(5): 409-17.
41. Rao, M.J., 2007. Globalization, Technology, and Competition: IPRs, Indian Pharmaceutical Industry and WTO, Serials Publications, New Delhi.
42. Reddy, A.K., 2004. Address to Pharmacophore International Symposium, Hyderabad.
43. Roumeliotis, G., 2006. India set to overtake Italy in API production, www.drugresearcher.com/news/ng.asp?id=67610.
44. Sawant, M., 2006. Outsourcing: shifting paradigms, www.pharmabiz.com/ article/detnews.asp?articleid=33676§ionid=50.
45. Saxenian, A., 2004. 'Taiwan's Hsinchu Region: Imitator and Partner for Silicon Valley', in Bresnahan, T., and A. Gambardella (eds), Building High-Tech Clusters: Silicon Valley and beyond, pp. 190-228, Cambridge University Press, Cambridge.
46. Sibal, K., 2006. Research in pharmaceutical industry, Lok Sabha: question no. 4383, answer by Minister of Science and Technology and Minister of Ocean Development, www.164.100.24.208/lsq14/quest.asp?qref=28223.
47. Singh, M.M., 2006. 'Will India Become the Global Centre for Pharmaceutical Research & Development?', Journal of Generic Medicines, 3(3): 194-200.
48. Stafford, A., 2005. 'Effective API Sourcing in Generic Pharmaceuticals', Pharma & Bio Ingredients, 2(1): 42-9.
49. Stankiewicz, R., 2001. 'The Cognitive Dynamics of Biotechnology and the Evolution of Its Technological System', in B. Carlsson (ed.), Technological Systems in the Bio Industries, pp. 35-52, Kluwer Academic Publishers, Boston.
50. Stevens, M., 2008. 'Mittals move is one more headache for FIRB', The Australian, 23 May, 21-2.
51. Thomas, P., 2005. Ranbaxy laboratories is challenging stereotypes and changing perceptions, www.pharmamanufacturing.com/articles/2005/ 309.html.
52. Vijay, G., 2003. '"Other Side" of New Industrialisation', Economic and Political Weekly, 38(48): 5026-30.
53. Vijay, G. 2005, 'Migration, Vulnerability and Insecurity in New Industrial Labour Markets', Economic and Political Weekly, 40(22): 2304-12.